ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
Dow Jones
39,069.59
0.01%
Brent Oil
83.015
0.21%
Bitcoin
67,882.69
-2.18%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Akoya BioSciences Inc (AKYA) Quote

Akoya BioSciences Inc

Akoya BioSciences Inc (AKYA)

NASDAQ
1.965
0.025
(1.29%)
Closed May 28 4:00PM
Delayed by 15 minutes
2.0195
0.0545
(2.77%)
After Hours: 7:52PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
2.0195
Bid
1.87
Ask
3.09
Volume
449,239
1.95 Day's Range 2.11
1.88 52 Week Range 8.80
Market Cap
96.316M
Previous Close
1.94
Open
1.95
Last Trade
100
@
2.0195
(formt)
Last Trade Time
Financial Volume
$ 895,023
VWAP
1.9923
Average Volume (3m)
284,590
Shares Outstanding
49,140,731
Dividend Yield
-
PE Ratio
-1.52
Earnings Per Share (EPS)
-1.29
Revenue
96.63M
Net Profit
-63.32M

About Akoya BioSciences Inc

Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clini... Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.akoyabio.com
Headquarters
Dover, Delaware, USA
Founded
1970
Akoya BioSciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker AKYA. The last closing price for Akoya BioSciences was $1.94. Over the last year, Akoya BioSciences shares have traded in a share price range of $ 1.88 to $ 8.80.

Akoya BioSciences currently has 49,140,731 shares outstanding. The market capitalization of Akoya BioSciences is $96.32 million. Akoya BioSciences has a price to earnings ratio (PE ratio) of -1.52.

AKYA Latest News

More News

Form 8-K - Current report

May 13 2024
Edgar (US Regulatory)

Akoya Biosciences Reports First Quarter 2024 Financial Results

MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter...

May 13 2024
GlobeNewswire Inc.

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

MARLBOROUGH, Mass. and FRANKFURT, Germany, May 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and NeraCare, a leading developer of laboratory...

May 09 2024
GlobeNewswire Inc.

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in...

May 06 2024
GlobeNewswire Inc.

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

MARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company...

May 02 2024
GlobeNewswire Inc.

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for...

April 22 2024
GlobeNewswire Inc.

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced it will highlight case studies featuring its Spatial...

April 05 2024
GlobeNewswire Inc.

Form 8-K - Current report

March 04 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.9005-30.83904109592.922.971.889959642.31378224CS
4-1.7805-46.85526315793.84.651.884966542.77158228CS
12-3.8205-65.41952054795.846.311.882845903.52821525CS
26-2.1705-51.80190930794.196.311.882374984.20169025CS
52-3.9205-66.00168350175.948.81.882210774.88876684CS
156-20.0605-90.853713768122.0822.151.881578519.1554558CS
260-23.9805-92.23269230772628.941.881598849.75030066CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
AKANAkanda Corporation
$ 4.07
(70.29%)
39.11M
TKLFYoshitsu Company Ltd
$ 0.3496
(53.33%)
84.5M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M
MRUSMerus NV
$ 59.92
(35.97%)
6.91M
VSTMVerastem Inc
$ 4.0901
(-66.42%)
19.68M
TOIIWOncology Institute Inc
$ 0.0443
(-55.61%)
280.55k
SNSESensei Biotherapeutics Inc
$ 0.7912
(-45.43%)
1.41M
GNLXGenelux Corporation
$ 2.61
(-43.26%)
3.32M
AUVIApplied UV Inc
$ 0.32
(-33.33%)
5.18M
LUCYInnovative Eyewear Inc
$ 0.983
(428.49%)
944.4M
GWAVGreenwave Technology Solutions Inc
$ 0.0843
(-4.85%)
428.98M
NCPLNetcapital Inc
$ 0.20
(14.42%)
191.35M
HLTHCue Health Inc
$ 0.0931
(-1.27%)
160.21M
ONMDOneMedNet Corporation
$ 2.251
(53.13%)
136.04M

Discussion

View Full Feed
dragoon76 dragoon76 10 minutes ago
Where's your data? Care to provide it for us? If you have none, it's not fair to criticize others for theirs...y'know.
COOP
RickNagra RickNagra 20 minutes ago
Oh wow. Big week on deck. Please take note. Varmit this is it. My secret sources boots on the ground have confirmed with my other friends colleagues teammates comrades strategically located in other parts of the world that we are headed to dollar land. Oh wow. Big press release in the morning.
GNCP
Ubgood Ubgood 23 minutes ago
Market cap under 100k soon..the five zero price coming...poor investment even for clowns..
CBGL
RickNagra RickNagra 24 minutes ago
Oh wow. $10 on deck. You are a genius. I am a genius. There should be no doubt. Oh wow. Oh wow to the power infinity. Oh wow. Oh boy oh girl.
DBMM
janice shell janice shell 28 minutes ago
That's interesting.

Thom Tillis is SUCH an idiot. On a completely different subject, he writes a comment letter about nearly EVERY SEC proposed rule. And those comments almost never have anything to do with what's being proposed. Nothing at all.
chen1992 chen1992 30 minutes ago
Mr. C, what odds do you think we have this week on the DOE giving their verdict on the extension request before Delfin’s permit expires 06/01?
TGLO
Phillipssamsung Phillipssamsung 42 minutes ago
No kidding. Rivers and rivers of it!! The diamond decoration was so successful they didn't bother to send the samples in. Probably the fake diamo d ring on glenns pinky. You k ow the type. They look to hire the geos community colleges graduate! Keep an eye on that share registry.
I wish I h
ACRL
Azart Azart 44 minutes ago
I am almost certain the next reverse from Scamus will be 100,000:1 which is why he bumped AS up to 250billion.
RNVA
Paul Wall Paul Wall 46 minutes ago
Hunnit this week. Crazy stuff is going to happen.
GME
arizona1 arizona1 50 minutes ago
Sadly, I know that. lol
glens0 glens0 50 minutes ago
https://www.youtube.com/watch?v=RbBuSg4GR7U
CEOS
BigJuan BigJuan 50 minutes ago
Lots of $RDAR chatter picking up here…

https://x.com/crossstocks/status/1794085570827657549?s=46&t=XqB5zh59gkZRCqfPE1hx3Q
RDAR
janice shell janice shell 53 minutes ago
Not to worry. It's all repeated endlessly. There's no possible way of missing a word.
lodas lodas 53 minutes ago
yo Boris?..... coattails?....what does this mean?... is this coattails your justification for waiting 15 years for more money from the chapter 11 closure?...does WMIH, now Coop, know about this clothing tailor who will make suits with coattails for former equity holders?....what is the name of this
COOP
BigJuan BigJuan 54 minutes ago
$GTVH lots brewing here, looks ready to go Big from here especially if Steff is done with the selling and reworks debt….

https://x.com/steffd415/status/1793986397659152647?s=46&t=XqB5zh59gkZRCqfPE1hx3Q
GTVH
JMCK6193 JMCK6193 54 minutes ago
He'll give him an Attaboy. Lol
RXMD
nowwhat2 nowwhat2 55 minutes ago
3 days later


https://investorshub.advfn.com/uimage/uploads/2024/5/28/sdfffbtc_555_24_6m_w_27_3_line.jpg


3 days later


https://investorshub.advfn.com/uimage/uploads/2024/5/28/apbvybtc_555_27_6m_w_4_3_line.jpg


BTCUSD
arizona1 arizona1 55 minutes ago
Being on PT and always going to sleep late, I miss the juiciest parts in the morning. I have to rely on twitter and iHub sleuths. lol
BigJuan BigJuan 58 minutes ago
$GTVH making some nice moves there holding gains and pushing higher :)
GTVH
janice shell janice shell 1 hour ago
He may pretend, though... I suspect his attorneys are not getting a good night's sleep.

Your Recent History

NASDAQ
AKYA
Akoya BioSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved